The Clinical Research Management Office (CRMO) is the administrative shared resource for the conduct of clinical search at the LCC. The Director of the CRMO, Michael J. Hawkins, M.D., has extensive experience in the conduct and administration of clinical research. The functions of the CRMO are to: facilitate the conduct of clinical search by providing support to clinical researchers and provide regulatory oversight of clinical research. The supervisor for Research Nursing (SRN) has 17 years of clinical oncology, research, and managerial experience and has direct supervisory responsibility for 11 research nurses, 3 data managers, 3 research assistants and 2 protocol coordinators. The Protocol Office, under the SRN's supervision, maintains files on each protocol submitted to the CRMO, submits protocols, amendments, annual reviews and adverse drug reaction reports to the IRB; and maintains current copies of open protocols throughout the LCC. The Supervisor of Research Operations has over 10 years of broad and extensive nursing experience and is responsible for quality control of the CRMO and implementation of new procedures. Support for two research nurses assigned to pilot institutional trials in bon arrow transplantation and developmental therapeutics is also requested in this application. With considerable support from the LCC, the CRMO has established a Clinical Research Database that contains data on each patient who goes onto a clinical protocol, electronically downloads data from the Georgetown Hospital Information System, d provides weekly reports for investigators on LCC single institution trials. Since the last CCSG review, the CRMO, together with the Clinical Protocol Review and Monitoring system and the Biostatistics Shared Resource, been extensively reorganized under new leadership to provides strong and extensive support for LCC clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-10
Application #
6203163
Study Section
Project Start
1999-07-30
Project End
2000-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Akinyemiju, Tomi F; Demb, Joshua; Izano, Monika A et al. (2018) The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health 63:787-797
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Furth, Priscilla A (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocr Relat Cancer :
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Gusev, Yuriy; Bhuvaneshwar, Krithika; Song, Lei et al. (2018) The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data 5:180158
Oppong, Bridget A; Dash, Chiranjeev; O'Neill, Suzanne et al. (2018) Breast density in multiethnic women presenting for screening mammography. Breast J 24:334-338
Fernandez, Harvey R; Gadre, Shreyas M; Tan, Mingjun et al. (2018) The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ 25:1239-1258
Schmidt, Marcel Oliver; Garman, Khalid Ammar; Lee, Yong Gu et al. (2018) The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation. J Invest Dermatol 138:179-188

Showing the most recent 10 out of 1120 publications